KOÇ, E. R. Et Al. 2022. Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study. MS Days VII , (Nevşehir, Turkey).

KOÇ, E. R., SARIDAŞ, F., CEYLAN, D., ÖZKAYA, G., & TURAN, Ö. F., (2022). Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study . MS Days VII, Nevşehir, Turkey

KOÇ, EMİNE Et Al. "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study," MS Days VII, Nevşehir, Turkey, 2022

KOÇ, EMİNE R. Et Al. "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study." MS Days VII , Nevşehir, Turkey, 2022

KOÇ, E. R. Et Al. (2022) . "Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study." MS Days VII , Nevşehir, Turkey.

@conferencepaper{conferencepaper, author={EMİNE RABİA KOÇ Et Al. }, title={Real world experience of Ocrelizumab in MS in the Turkish population: A single-center study}, congress name={MS Days VII}, city={Nevşehir}, country={Turkey}, year={2022}}